ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Kidney Medicine Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-17C8604
Home | Market Reports | Health| Pharmacy
Global Kidney Medicine Market Insights Forecast to 2028
BUY CHAPTERS

Global Kidney Medicine Market Research Report 2025

Code: QYRE-Auto-17C8604
Report
September 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Roche
Sanofi
Novartis
Amgen Inc
Xiuzheng Pharmaceutical Group
Xiaolin Zhiyao
Henan Lingrui Pharmaceutical
Kuihua yaoye
Sanjiu Pharmaceutical
Harbin Pharmaceutical Group

Kidney Medicine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Kidney Medicine Market

Kidney Medicine Market

The global market for Kidney Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Kidney medicine is used for deficiency of kidney essence, impotence and smoothness caused by insufficient yuan Yang, cold waist and knee, short breath and fatigue
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Kidney Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Medicine.
The Kidney Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Kidney Medicine Market Report

Report Metric Details
Report Name Kidney Medicine Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Pharmacy
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Roche, Sanofi, Novartis, Amgen, Xiuzheng Pharmaceutical Group, Xiaolin Zhiyao, Henan Lingrui Pharmaceutical, Kuihua yaoye, Sanjiu Pharmaceutical, Harbin Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Kidney Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Kidney Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Kidney Medicine Market report?

Ans: The main players in the Kidney Medicine Market are Pfizer, Roche, Sanofi, Novartis, Amgen, Xiuzheng Pharmaceutical Group, Xiaolin Zhiyao, Henan Lingrui Pharmaceutical, Kuihua yaoye, Sanjiu Pharmaceutical, Harbin Pharmaceutical Group

What are the Application segmentation covered in the Kidney Medicine Market report?

Ans: The Applications covered in the Kidney Medicine Market report are Hospital, Pharmacy, Others

What are the Type segmentation covered in the Kidney Medicine Market report?

Ans: The Types covered in the Kidney Medicine Market report are Tablet, Capsule, Oral Liquid

Recommended Reports

Kidney and Renal Treatment

Pharmaceutical Medicine Market

Diagnosis and Related Drugs

1 Kidney Medicine Market Overview
1.1 Product Definition
1.2 Kidney Medicine by Type
1.2.1 Global Kidney Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Oral Liquid
1.3 Kidney Medicine by Application
1.3.1 Global Kidney Medicine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Kidney Medicine Market Size Estimates and Forecasts
1.4.1 Global Kidney Medicine Revenue 2020-2031
1.4.2 Global Kidney Medicine Sales 2020-2031
1.4.3 Global Kidney Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Kidney Medicine Market Competition by Manufacturers
2.1 Global Kidney Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Kidney Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Kidney Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Kidney Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Kidney Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Kidney Medicine, Product Type & Application
2.7 Global Key Manufacturers of Kidney Medicine, Date of Enter into This Industry
2.8 Global Kidney Medicine Market Competitive Situation and Trends
2.8.1 Global Kidney Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Kidney Medicine Players Market Share by Revenue
2.8.3 Global Kidney Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Kidney Medicine Market Scenario by Region
3.1 Global Kidney Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Kidney Medicine Sales by Region: 2020-2031
3.2.1 Global Kidney Medicine Sales by Region: 2020-2025
3.2.2 Global Kidney Medicine Sales by Region: 2026-2031
3.3 Global Kidney Medicine Revenue by Region: 2020-2031
3.3.1 Global Kidney Medicine Revenue by Region: 2020-2025
3.3.2 Global Kidney Medicine Revenue by Region: 2026-2031
3.4 North America Kidney Medicine Market Facts & Figures by Country
3.4.1 North America Kidney Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Kidney Medicine Sales by Country (2020-2031)
3.4.3 North America Kidney Medicine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Kidney Medicine Market Facts & Figures by Country
3.5.1 Europe Kidney Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Kidney Medicine Sales by Country (2020-2031)
3.5.3 Europe Kidney Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Kidney Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Kidney Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Kidney Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Kidney Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Kidney Medicine Market Facts & Figures by Country
3.7.1 Latin America Kidney Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Kidney Medicine Sales by Country (2020-2031)
3.7.3 Latin America Kidney Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Kidney Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Kidney Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Kidney Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Kidney Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Kidney Medicine Sales by Type (2020-2031)
4.1.1 Global Kidney Medicine Sales by Type (2020-2025)
4.1.2 Global Kidney Medicine Sales by Type (2026-2031)
4.1.3 Global Kidney Medicine Sales Market Share by Type (2020-2031)
4.2 Global Kidney Medicine Revenue by Type (2020-2031)
4.2.1 Global Kidney Medicine Revenue by Type (2020-2025)
4.2.2 Global Kidney Medicine Revenue by Type (2026-2031)
4.2.3 Global Kidney Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Kidney Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Kidney Medicine Sales by Application (2020-2031)
5.1.1 Global Kidney Medicine Sales by Application (2020-2025)
5.1.2 Global Kidney Medicine Sales by Application (2026-2031)
5.1.3 Global Kidney Medicine Sales Market Share by Application (2020-2031)
5.2 Global Kidney Medicine Revenue by Application (2020-2031)
5.2.1 Global Kidney Medicine Revenue by Application (2020-2025)
5.2.2 Global Kidney Medicine Revenue by Application (2026-2031)
5.2.3 Global Kidney Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Kidney Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Kidney Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Kidney Medicine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Company Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Kidney Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Roche Kidney Medicine Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Kidney Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Kidney Medicine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Kidney Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Kidney Medicine Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Company Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Kidney Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Amgen Kidney Medicine Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Xiuzheng Pharmaceutical Group
6.6.1 Xiuzheng Pharmaceutical Group Company Information
6.6.2 Xiuzheng Pharmaceutical Group Description and Business Overview
6.6.3 Xiuzheng Pharmaceutical Group Kidney Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Xiuzheng Pharmaceutical Group Kidney Medicine Product Portfolio
6.6.5 Xiuzheng Pharmaceutical Group Recent Developments/Updates
6.7 Xiaolin Zhiyao
6.7.1 Xiaolin Zhiyao Company Information
6.7.2 Xiaolin Zhiyao Description and Business Overview
6.7.3 Xiaolin Zhiyao Kidney Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Xiaolin Zhiyao Kidney Medicine Product Portfolio
6.7.5 Xiaolin Zhiyao Recent Developments/Updates
6.8 Henan Lingrui Pharmaceutical
6.8.1 Henan Lingrui Pharmaceutical Company Information
6.8.2 Henan Lingrui Pharmaceutical Description and Business Overview
6.8.3 Henan Lingrui Pharmaceutical Kidney Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Henan Lingrui Pharmaceutical Kidney Medicine Product Portfolio
6.8.5 Henan Lingrui Pharmaceutical Recent Developments/Updates
6.9 Kuihua yaoye
6.9.1 Kuihua yaoye Company Information
6.9.2 Kuihua yaoye Description and Business Overview
6.9.3 Kuihua yaoye Kidney Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Kuihua yaoye Kidney Medicine Product Portfolio
6.9.5 Kuihua yaoye Recent Developments/Updates
6.10 Sanjiu Pharmaceutical
6.10.1 Sanjiu Pharmaceutical Company Information
6.10.2 Sanjiu Pharmaceutical Description and Business Overview
6.10.3 Sanjiu Pharmaceutical Kidney Medicine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sanjiu Pharmaceutical Kidney Medicine Product Portfolio
6.10.5 Sanjiu Pharmaceutical Recent Developments/Updates
6.11 Harbin Pharmaceutical Group
6.11.1 Harbin Pharmaceutical Group Company Information
6.11.2 Harbin Pharmaceutical Group Description and Business Overview
6.11.3 Harbin Pharmaceutical Group Kidney Medicine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Harbin Pharmaceutical Group Kidney Medicine Product Portfolio
6.11.5 Harbin Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Kidney Medicine Industry Chain Analysis
7.2 Kidney Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Kidney Medicine Production Mode & Process Analysis
7.4 Kidney Medicine Sales and Marketing
7.4.1 Kidney Medicine Sales Channels
7.4.2 Kidney Medicine Distributors
7.5 Kidney Medicine Customer Analysis
8 Kidney Medicine Market Dynamics
8.1 Kidney Medicine Industry Trends
8.2 Kidney Medicine Market Drivers
8.3 Kidney Medicine Market Challenges
8.4 Kidney Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Roche
Sanofi
Novartis
Amgen Inc
Xiuzheng Pharmaceutical Group
Xiaolin Zhiyao
Henan Lingrui Pharmaceutical
Kuihua yaoye
Sanjiu Pharmaceutical
Harbin Pharmaceutical Group
List of Tables
 Table 1. Global Kidney Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Kidney Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Kidney Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Kidney Medicine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Kidney Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Kidney Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Kidney Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Kidney Medicine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Kidney Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Kidney Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Kidney Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Kidney Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Kidney Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Kidney Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Kidney Medicine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Kidney Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Kidney Medicine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Kidney Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Kidney Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Kidney Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Kidney Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Kidney Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Kidney Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Kidney Medicine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Kidney Medicine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Kidney Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Kidney Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Kidney Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Kidney Medicine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Kidney Medicine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Kidney Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Kidney Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Kidney Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Kidney Medicine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Kidney Medicine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Kidney Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Kidney Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Kidney Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Kidney Medicine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Kidney Medicine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Kidney Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Kidney Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Kidney Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Kidney Medicine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Kidney Medicine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Kidney Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Kidney Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Kidney Medicine Sales (K Units) by Type (2020-2025)
 Table 51. Global Kidney Medicine Sales (K Units) by Type (2026-2031)
 Table 52. Global Kidney Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Kidney Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Kidney Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Kidney Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Kidney Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Kidney Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Kidney Medicine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Kidney Medicine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Kidney Medicine Sales (K Units) by Application (2020-2025)
 Table 61. Global Kidney Medicine Sales (K Units) by Application (2026-2031)
 Table 62. Global Kidney Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Kidney Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Kidney Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Kidney Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Kidney Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Kidney Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Kidney Medicine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Kidney Medicine Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Kidney Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Kidney Medicine Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Roche Company Information
 Table 76. Roche Description and Business Overview
 Table 77. Roche Kidney Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Roche Kidney Medicine Product
 Table 79. Roche Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Kidney Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Kidney Medicine Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Kidney Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis Kidney Medicine Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Amgen Company Information
 Table 91. Amgen Description and Business Overview
 Table 92. Amgen Kidney Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Amgen Kidney Medicine Product
 Table 94. Amgen Recent Developments/Updates
 Table 95. Xiuzheng Pharmaceutical Group Company Information
 Table 96. Xiuzheng Pharmaceutical Group Description and Business Overview
 Table 97. Xiuzheng Pharmaceutical Group Kidney Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Xiuzheng Pharmaceutical Group Kidney Medicine Product
 Table 99. Xiuzheng Pharmaceutical Group Recent Developments/Updates
 Table 100. Xiaolin Zhiyao Company Information
 Table 101. Xiaolin Zhiyao Description and Business Overview
 Table 102. Xiaolin Zhiyao Kidney Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Xiaolin Zhiyao Kidney Medicine Product
 Table 104. Xiaolin Zhiyao Recent Developments/Updates
 Table 105. Henan Lingrui Pharmaceutical Company Information
 Table 106. Henan Lingrui Pharmaceutical Description and Business Overview
 Table 107. Henan Lingrui Pharmaceutical Kidney Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Henan Lingrui Pharmaceutical Kidney Medicine Product
 Table 109. Henan Lingrui Pharmaceutical Recent Developments/Updates
 Table 110. Kuihua yaoye Company Information
 Table 111. Kuihua yaoye Description and Business Overview
 Table 112. Kuihua yaoye Kidney Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Kuihua yaoye Kidney Medicine Product
 Table 114. Kuihua yaoye Recent Developments/Updates
 Table 115. Sanjiu Pharmaceutical Company Information
 Table 116. Sanjiu Pharmaceutical Description and Business Overview
 Table 117. Sanjiu Pharmaceutical Kidney Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Sanjiu Pharmaceutical Kidney Medicine Product
 Table 119. Sanjiu Pharmaceutical Recent Developments/Updates
 Table 120. Harbin Pharmaceutical Group Company Information
 Table 121. Harbin Pharmaceutical Group Description and Business Overview
 Table 122. Harbin Pharmaceutical Group Kidney Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Harbin Pharmaceutical Group Kidney Medicine Product
 Table 124. Harbin Pharmaceutical Group Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Kidney Medicine Distributors List
 Table 128. Kidney Medicine Customers List
 Table 129. Kidney Medicine Market Trends
 Table 130. Kidney Medicine Market Drivers
 Table 131. Kidney Medicine Market Challenges
 Table 132. Kidney Medicine Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Kidney Medicine
 Figure 2. Global Kidney Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Kidney Medicine Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Oral Liquid Product Picture
 Figure 7. Global Kidney Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Kidney Medicine Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Pharmacy
 Figure 11. Others
 Figure 12. Global Kidney Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Kidney Medicine Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Kidney Medicine Sales (2020-2031) & (K Units)
 Figure 15. Global Kidney Medicine Average Price (US$/Unit) & (2020-2031)
 Figure 16. Kidney Medicine Report Years Considered
 Figure 17. Kidney Medicine Sales Share by Manufacturers in 2024
 Figure 18. Global Kidney Medicine Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Kidney Medicine Players: Market Share by Revenue in Kidney Medicine in 2024
 Figure 20. Kidney Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Kidney Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Kidney Medicine Sales Market Share by Country (2020-2031)
 Figure 23. North America Kidney Medicine Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Kidney Medicine Sales Market Share by Country (2020-2031)
 Figure 27. Europe Kidney Medicine Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Kidney Medicine Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Kidney Medicine Revenue Market Share by Region (2020-2031)
 Figure 35. China Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Kidney Medicine Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Kidney Medicine Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Kidney Medicine Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Kidney Medicine Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Kidney Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Kidney Medicine by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Kidney Medicine by Type (2020-2031)
 Figure 57. Global Kidney Medicine Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Kidney Medicine by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Kidney Medicine by Application (2020-2031)
 Figure 60. Global Kidney Medicine Price (US$/Unit) by Application (2020-2031)
 Figure 61. Kidney Medicine Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Renal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs to Treat Chronic Kidney Disease Market Research Report 2024
Global Chronic Kidney Disease Treatment Market Research Report 2025
Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Medical Devices Market Research Report 2024
Global Proteinuria Treatment Market Insights Forecast to 2030
End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urology Drugs Market Insights Forecast to 2030
Global Chronic Kidney Disease CKD Treatment Market Research Report 2025
Global Renal Disease Treatment Market Research Report 2024
Kidney Fibrosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Fibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Renal Fibrosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Drug Therapy Market Insights Forecast to 2030
Late Stage Chronic Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Kidney Dialysis Machines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Diseases Drug Market Insights Forecast to 2030
Global Artificial Kidney Machine Market Research Report 2024
Global Chronic Kidney Disease Drugs Market Research Report 2025
Global Renal Biomarker Market Research Report 2025

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions